Viridian Therapeutics (1S1) Revenue

2 Followers

Viridian Therapeutics Revenue

Viridian Therapeutics had a revenue of 284.00K in the quarter ending Jun 30, 2026, with 101.42%. This bring the company's revenue in the last twelve months to 71.13M, Decreased 0.29%. In the fiscal year ending Dec 31, 2025, Viridian Therapeutics had annual revenue of 70.85M with 23359.93% growth.

Revenue (ttm)

71.13M

Revenue Growth

21609.37%

P/S Ratio

31.10

Revenue/Employee

€281,147

Employees

252

Market Cap

€2.20B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	70.85M	70.55M	+23,359.93%
Dec 31, 2024	302.00K	-12.00K	-3.82%
Dec 31, 2023	314.00K	-1.46M	-82.28%
Dec 31, 2022	1.77M	-1.19M	-40.20%
Dec 31, 2021	2.96M	1.91M	+182.19%
Dec 31, 2020	1.05M	-3.41M	-76.46%
Dec 31, 2019	4.46M	-3.92M	-46.80%
Dec 31, 2018	8.39M	4.38M	+109.49%
Dec 31, 2017	4.00M	―	―